Error analysis in Barker's method: extension to ternary systems

An extension of Barker's method to ternary systems is briefly outlined. Expressions for the standard deviations of the excess molar Gibbs free energy and the equilibrium pressure as functions of composition are obtained. These expressions are applied to accurate experimental data for the cryogenic (liquid) mixture CH3F+N2O+Xe recently measured in our laboratory.http://www.sciencedirect.com/science/article/B6TG2-3VGSGDR-4/1/e3c29abb1f0602ee677ab2a9887b8ee

PVT Property Measurements for Some Aliphatic Esters from (298 to 393) K and up to 35 MPa

The results of PVT measurements of the liquid phase within the temperature range of (298 to 393) K and up to 35 MPa are presented for some aliphatic esters. Measurements were made by means of a vibrating-tube densimeter, model DMA 512P from Anton Parr. The calibration of the densimeter was performed with water and n-heptane as reference fluids. The experimental PVT data have been correlated by a Tait equation. This equation gives excellent results when used to predict the density of the esters using the method proposed by Thomson et al. (AIChE J. 1982, 28, 671−676). Isothermal compressibilities, isobaric expansivities, thermal pressure coefficients, and changes in the isobaric heat capacity have been calculated from the volumetric data

Densities and Derived Thermodynamic Properties of Imidazolium-, Pyridinium-, Pyrrolidinium-, and Piperidinium-Based Ionic Liquids

In the present work, experimental density measurements are reported along with the derived thermodynamic properties, such as the isothermal compressibility (κT), the isobaric expansivity (αp), and the thermal pressure coefficient (γv) for imidazolium-, pyridinium-, pyrrolidinium-, and piperidinium-based ionic liquids (ILs), namely, 1-ethyl-3-methylimidazolium trifluoromethanesulfonate [C2mim][CF3SO3], 3-methyl-1-propylpyridinium bis(trifluoromethylsulfonyl)imide [C3mpy][NTf2], 1-methyl-1-propylpyrrolidinium bis(trifluoromethylsulfonyl)imide [C3mpyr][NTf2], 1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide [C4mpyr][NTf2], and 1-methyl-1-propylpiperidinium bis(trifluoromethylsulfonyl)imide [C3mpip][NTf2] in the pressure (0.10 < P/MPa < 35.00) and temperature (293.15 < T/K < 393.15) domains. These ILs were chosen to provide an understanding of the influence of the cation and anion on the properties under study. Experimental densities are correlated with the Tait equation with an average absolute relative deviation (AARD) better than 0.02 %. It is shown that experimental densities are in good agreement with the densities obtained by the predictive method previously proposed by us.http://dx.doi.org/10.1021/je700670

Surface and interfacial tensions of the systems water + n-butyl acetate + methanol and water + n-pentyl acetate + methanol at 303.15 K

The surface tension in the homogeneous domain of the ternary liquid mixtures water + n-butyl acetate + methanol and water + n-pentyl acetate + methanol as well as of the constituent binaries has been measured at 303.15 K and atmospheric pressure. The respective excess surface tension was correlated as a function of the composition using empirical and thermodynamic-based relations. The liquid interfacial tension was measured in the liquid-liquid equilibrium range at the same conditions of temperature and pressure.http://www.sciencedirect.com/science/article/B6TG2-487TYBG-1/1/a39b0ffcd3de8658fe47103f160785e

Physicians&apos; guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

Background: Physicians&apos; adherence to guideline-recommended therapy is associated with short-term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF). However, its impact on longer-term outcomes is poorly documented. Here, we present results from the 18-month follow-up of the QUALIFY registry. Methods and results: Data at 18 months were available for 6118 ambulatory HFrEF patients from this international prospective observational survey. Adherence was measured as a continuous variable, ranging from 0 to 1, and was assessed for five classes of recommended HF medications and dosages. Most deaths were cardiovascular (CV) (228/394) and HF-related (191/394) and the same was true for unplanned hospitalizations (1175 CV and 861 HF-related hospitalizations, out of a total of 1541). According to univariable analysis, CV and HF deaths were significantly associated with physician adherence to guidelines. In multivariable analysis, HF death was associated with adherence level [subdistribution hazard ratio (SHR) 0.93, 95% confidence interval (CI) 0.87–0.99 per 0.1 unit adherence level increase; P = 0.034] as was composite of HF hospitalization or CV death (SHR 0.97, 95% CI 0.94–0.99 per 0.1 unit adherence level increase; P = 0.043), whereas unplanned all-cause, CV or HF hospitalizations were not (all-cause: SHR 0.99, 95% CI 0.9–1.02; CV: SHR 0.98, 95% CI 0.96–1.01; and HF: SHR 0.99, 95% CI 0.96–1.02 per 0.1 unit change in adherence score; P = 0.52, P = 0.2, and P = 0.4, respectively). Conclusion: These results suggest that physicians&apos; adherence to guideline-recommended HF therapies is associated with improved outcomes in HFrEF. Practical strategies should be established to improve physicians&apos; adherence to guidelines. © 2019 The Authors. European Journal of Heart Failure © 2019 European Society of Cardiolog